Rockwell Medical IncRMTI
Price$8.57Intrinsic value$7.5712% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $7.57median of 2 methodsbased on filings through 31 Dec 2025
Market Price $8.57Price as of 1 Oct 2026
Margin of Safety -11.7%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 61.8%/yr (balance of the path).48.4% per year
Years 6–10: glide to demonstrated growth own history 49.2%, capped at 20%
Per-year rates
Yr 653.4%Yr 745.1%Yr 836.7%Yr 928.4%Yr 1020.0%
61.8% → 20.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1118.3%Yr 1216.6%Yr 1314.9%Yr 1413.2%Yr 1511.5%Yr 169.8%Yr 178.1%Yr 186.4%Yr 194.7%Yr 203.0%
20.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)49.2%
Discount rate (cost of equity) 11.3%
Volatility vs market (adjusted beta)1.41

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetRockwell Medical IncRMTIHealth Care
Valuation
P/E—
P/S0.5×
P/B8.4×
EV / Revenue0.2×
EV / EBITDA-6.3×
Profitability
Gross margin16.9%
Operating margin-6.8%
Net margin-7.7%
FCF margin-1.9%
Returns
ROE-14.4%
ROA-9.3%
ROIC—
Growth
Revenue growth (YoY)-31.8%
5-yr fwd EPS growth48.4%
Financial strength
Debt / Equity0.24×
Current ratio—
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.